查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1938330

過敏診斷市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品、過敏原類型、檢測方法、最終用戶、地區和競爭格局分類），2021-2031年

Allergy Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Allergy Type, By Test, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球過敏診斷市場預計將從 2025 年的 65.8 億美元成長到 2031 年的 129.8 億美元，複合年成長率達到 11.99%。

此領域利用醫療設備、耗材和檢測方法來識別過敏原特異性抗體和細胞反應，從而實現對環境和食物來源過敏原的臨床診斷。市場成長的主要驅動力是全球特應性疾病發生率的上升以及臨床上對早期檢測以有效管理慢性疾病的需求。根據美國氣喘和過敏基金會 (AAFA) 2024 年的一份報告，美國約有 1 億人患有各種過敏性疾病，這凸顯了建立可靠的診斷框架以應對這一日益嚴重的健康問題的迫切需求。

市場概覽
預測期 2027-2031
市場規模：2025年 65.8億美元
市場規模：2031年 129.8億美元
複合年成長率：2026-2031年 11.99%
成長最快的細分市場 檢測試劑盒
最大的市場 亞太地區

然而，自動化診斷平台的高昂實施和營運成本為市場帶來了許多障礙。這些資金限制常常阻礙小規模實驗室和資源有限的醫療機構部署全面的檢測方案。因此，在醫療預算緊張的發展中經濟體，高成本抑制了市場滲透，有效限制了這些重要診斷工具的廣泛應用。

市場促進因素

全球過敏性疾病及其併發症的盛行率不斷上升，加上快速的都市化和環境污染加劇，成為過敏診斷市場成長的主要驅動力。氣候變遷導致空氣品質惡化和花粉季延長，增加了呼吸道過敏的發生率，從而催生了對更頻繁、更精準的篩檢通訊協定的需求。根據美國氣喘和過敏基金會 (AAFA) 2024 年 3 月發布的《2024 年首都地區過敏狀況》報告，約 25.7% 的美國成年人被診斷出患有季節性過敏。這種普遍存在的疾病負擔迫使醫療保健提供者使用綜合診斷方案來區分過敏性鼻炎與其他呼吸道疾病，從而推動了免疫檢測設備和耗材試劑盒在臨床環境中的應用。

同時，嚴重食物過敏和食物超敏反應發生率的快速成長是推動市場發展的主要因素，因此，精準的風險評估工具至關重要。食物超敏反應的複雜性促使臨床關注轉向成分解析診斷，以識別引發過敏反應的特定蛋白質。世界過敏組織2024年3月發表的一篇報導指出，FARE患者登記庫中46%的患者曾發生食物誘發的過敏反應，凸顯了進行更高級風險分層的必要性。此外，英國食品標準局（FSA）2024年8月的報告顯示，英格蘭因食物誘發的過敏反應而入院治療的人數已增至每10萬人4.02人，這更加凸顯了臨床上迫切需要可靠的診斷干預措施。

市場挑戰

自動化診斷平台高昂的採集費用和營運成本嚴重阻礙因素了過敏診斷市場的擴張。中小實驗室往往缺乏足夠的資金來購買此類設備以及承擔耗材和維護的持續成本。這項經濟障礙使得資源充足的醫療中心難以獲得全面的檢測服務，導致小規模的機構和資源匱乏的地區無法獲得充分的服務。因此，在醫療支出受到嚴格控制和優先考慮的發展中經濟體，市場滲透更是難上加難。

根據歐洲過敏與臨床免疫學會的估計，到2024年，歐洲約有1.5億人將患有慢性過敏性疾病。儘管患病率高且診斷需求巨大，但小規模醫療機構無力實施自動化系統，導致臨床需求與檢測能力之間存在差距。大多數醫療機構診斷基礎設施的資金不足限制了患者就醫，直接限制了檢測量，並阻礙了整體市場成長。

市場趨勢

將人工智慧 (AI) 和機器學習 (ML) 整合到診斷工作流程中，透過自動化解讀複雜的免疫學數據，從根本上改變了過敏檢測的方式。這些先進的演算法分析患者的病歷和致敏模式，以比傳統人工評估更高的準確率預測過敏原反應，從而顯著減輕臨床醫生的行政負擔。正如 2024 年 10 月發表於《歐洲公共衛生雜誌》的論文「AI 增強型過敏診斷」中所詳述的，一項約 300 名患者的臨床試驗證實，AI 輔助方法在保持高靈敏度的同時，平均每位醫務人員可節省 40 分鐘的檢測時間。這項技術變革透過簡化高風險患者的分層流程和最佳化臨床決策，有效緩解了專科醫師短缺的問題。

同時，市場正經歷著向多重免疫檢測和微陣列平台的重大轉變，這些平台能夠從單一血清樣本中同時定量檢測針對多種過敏原的特異性IgE抗體。這一發展趨勢推動了成分解析診斷（CRD）的廣泛應用，使醫療專業人員能夠比單次檢測法更有效地區分真正的致敏反應和交叉反應。在該領域，AliveDx於2024年7月發布新聞稿，宣布其專有的微陣列免疫免疫檢測已獲得監管部門核准，該技術可檢測30多種不同的過敏原，包括食物和吸入性蛋白質。此類平台對於制定針對多重過敏患者的個人化管理方案而言正變得越來越重要，且無需採集大量血液樣本。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球過敏診斷市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品分類（檢測試劑盒、儀器、耗材、服務）
    • 過敏類型（食物、季節性、藥物、吸入性、過敏性/接觸性、其他）
    • 依測試方法（體內測試、體外測試）
    • 依最終使用者（醫院、診斷檢查室、學術研究機構等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美過敏診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲過敏診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區過敏診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲過敏診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲過敏診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球過敏診斷市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Danaher Corporation
  • Hologic, Inc.
  • BioMerieux SA
  • F. Hoffmann-La Roche AG
  • Laboratory Corporation of America Holdings
  • Allergy Therapeutics plc
  • Indoor Biotechnologies, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 7424

The Global Allergy Diagnostics Market is projected to expand from USD 6.58 Billion in 2025 to USD 12.98 Billion by 2031, achieving a CAGR of 11.99%. This sector involves the medical instruments, consumables, and assays used to identify allergen-specific antibodies or cellular responses, enabling the clinical diagnosis of hypersensitivities to environmental and food-based triggers. Market growth is primarily fueled by the rising global incidence of atopic diseases and the clinical necessity for early detection to manage chronic conditions effectively. As reported by the Asthma and Allergy Foundation of America in 2024, approximately 100 million individuals in the United States live with various allergic conditions, underscoring the critical need for reliable diagnostic frameworks to address this expanding health burden.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 6.58 Billion
Market Size 2031USD 12.98 Billion
CAGR 2026-203111.99%
Fastest Growing SegmentAssay Kits
Largest MarketAsia Pacific

However, the market encounters significant hurdles due to the high acquisition and operational costs associated with automated diagnostic platforms. These financial constraints frequently limit the adoption of comprehensive testing panels in smaller laboratories and resource-limited healthcare settings. Consequently, high costs impede market penetration in developing economic regions where healthcare budgets are tight, effectively restricting the widespread availability of these essential diagnostic tools.

Market Driver

The rising global prevalence of allergic diseases and comorbidities, exacerbated by rapid urbanization and environmental pollution, serves as a primary catalyst for the growth of the allergy diagnostics market. As climate change degrades air quality and prolongs pollen seasons, the frequency of respiratory sensitizations has increased, creating a demand for more frequent and precise screening protocols. According to the March 2024 '2024 Allergy Capitals' report by the Asthma and Allergy Foundation of America, approximately 25.7% of adults in the United States have a diagnosed seasonal allergy. This widespread burden compels healthcare providers to utilize comprehensive diagnostic panels to distinguish allergic rhinitis from other respiratory conditions, thereby boosting the deployment of immunoassay analyzers and consumable kits in clinical settings.

Simultaneously, the market is significantly propelled by the surging incidence of severe food allergies and dietary sensitivities, which necessitate accurate risk assessment tools. The complexity of food-based hypersensitivities has shifted clinical focus toward component-resolved diagnostics to pinpoint specific proteins that trigger anaphylaxis. In the 'The clinical burden of food allergies' article published by the World Allergy Organization in March 2024, 46% of patients in the FARE Patient Registry reported experiencing food-induced anaphylaxis, highlighting the need for advanced stratification. Furthermore, the Food Standards Agency's August 2024 report noted that hospital admissions for food-induced anaphylaxis in England rose to 4.02 per 100,000 people, reinforcing the urgent clinical imperative for robust diagnostic interventions.

Market Challenge

The substantial acquisition and operational expenses tied to automated diagnostic platforms pose a major restraint on the expansion of the allergy diagnostics market. Small and medium-sized laboratories often lack the capital budget necessary to purchase these instruments or support the recurring costs of consumables and maintenance. This financial barrier effectively restricts the use of comprehensive testing panels to well-funded medical centers, leaving smaller facilities and resource-constrained regions underserved. Consequently, the market struggles to penetrate developing economic regions where healthcare spending is strictly monitored and prioritized.

According to the European Academy of Allergy and Clinical Immunology, approximately 150 million citizens across Europe were estimated to suffer from chronic allergic diseases in 2024. Despite this high prevalence and the associated need for diagnosis, the inability of smaller healthcare providers to afford automated systems creates a disparity between clinical demand and testing availability. When diagnostic infrastructure is financially inaccessible to a large segment of the healthcare landscape, patient access is reduced, which directly limits the volume of assays performed and impedes overall market growth.

Market Trends

The integration of Artificial Intelligence (AI) and Machine Learning (ML) into diagnostic workflows is fundamentally transforming allergy testing by automating the interpretation of complex immunological data. These advanced algorithms analyze patient history and sensitization patterns to predict allergen reactivity with greater precision than traditional manual assessments, significantly lowering administrative burdens on clinicians. As detailed in the 'AI-Enhanced Allergy Diagnostics' article within the European Journal of Public Health in October 2024, clinical trials involving around 300 patients showed that AI-supported methods saved medical staff an average of 40 minutes per patient while maintaining high sensitivity. This technological shift addresses specialist shortages by streamlining the stratification of high-risk patients and optimizing clinical decision-making.

Concurrently, the market is witnessing a decisive shift toward Multiplex Immunoassay and Microarray Platforms, which allow for the simultaneous quantification of specific IgE antibodies against a vast array of allergens from a single serum sample. This evolution supports the broader adoption of Component-Resolved Diagnostics (CRD), enabling practitioners to differentiate between genuine sensitization and cross-reactivity more effectively than single-plex assays. A significant advancement in this area was highlighted by AliveDx in a July 2024 press release, announcing regulatory approval for its proprietary microarray immunoassay designed to detect over 30 distinct allergens, including both food and inhalant proteins. Such platforms are increasingly critical for developing personalized management plans for polysensitized individuals without requiring large blood volumes.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Danaher Corporation
  • Hologic, Inc.
  • BioMerieux SA
  • F. Hoffmann-La Roche AG
  • Laboratory Corporation of America Holdings
  • Allergy Therapeutics plc
  • Indoor Biotechnologies, Inc.

Report Scope

In this report, the Global Allergy Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Allergy Diagnostics Market, By Product

  • Assay Kits
  • Instruments
  • Consumables
  • Services

Allergy Diagnostics Market, By Allergy Type

  • Food
  • Seasonal
  • Drug
  • Inhalant
  • Anaphylaxis/Contact Allergies
  • Others

Allergy Diagnostics Market, By Test

  • In Vivo
  • In Vitro

Allergy Diagnostics Market, By End User

  • Hospital
  • Diagnostic Laboratory
  • Academic and Research Institutes
  • Others

Allergy Diagnostics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Allergy Diagnostics Market.

Available Customizations:

Global Allergy Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Allergy Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Assay Kits, Instruments, Consumables, Services)
    • 5.2.2. By Allergy Type (Food, Seasonal, Drug, Inhalant, Anaphylaxis/Contact Allergies, Others)
    • 5.2.3. By Test (In Vivo, In Vitro)
    • 5.2.4. By End User (Hospital, Diagnostic Laboratory, Academic and Research Institutes, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Allergy Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Allergy Type
    • 6.2.3. By Test
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Allergy Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Allergy Type
        • 6.3.1.2.3. By Test
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Allergy Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Allergy Type
        • 6.3.2.2.3. By Test
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Allergy Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Allergy Type
        • 6.3.3.2.3. By Test
        • 6.3.3.2.4. By End User

7. Europe Allergy Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Allergy Type
    • 7.2.3. By Test
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Allergy Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Allergy Type
        • 7.3.1.2.3. By Test
        • 7.3.1.2.4. By End User
    • 7.3.2. France Allergy Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Allergy Type
        • 7.3.2.2.3. By Test
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Allergy Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Allergy Type
        • 7.3.3.2.3. By Test
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Allergy Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Allergy Type
        • 7.3.4.2.3. By Test
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Allergy Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Allergy Type
        • 7.3.5.2.3. By Test
        • 7.3.5.2.4. By End User

8. Asia Pacific Allergy Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Allergy Type
    • 8.2.3. By Test
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Allergy Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Allergy Type
        • 8.3.1.2.3. By Test
        • 8.3.1.2.4. By End User
    • 8.3.2. India Allergy Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Allergy Type
        • 8.3.2.2.3. By Test
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Allergy Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Allergy Type
        • 8.3.3.2.3. By Test
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Allergy Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Allergy Type
        • 8.3.4.2.3. By Test
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Allergy Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Allergy Type
        • 8.3.5.2.3. By Test
        • 8.3.5.2.4. By End User

9. Middle East & Africa Allergy Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Allergy Type
    • 9.2.3. By Test
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Allergy Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Allergy Type
        • 9.3.1.2.3. By Test
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Allergy Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Allergy Type
        • 9.3.2.2.3. By Test
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Allergy Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Allergy Type
        • 9.3.3.2.3. By Test
        • 9.3.3.2.4. By End User

10. South America Allergy Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Allergy Type
    • 10.2.3. By Test
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Allergy Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Allergy Type
        • 10.3.1.2.3. By Test
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Allergy Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Allergy Type
        • 10.3.2.2.3. By Test
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Allergy Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Allergy Type
        • 10.3.3.2.3. By Test
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Allergy Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Siemens Healthineers AG
  • 15.3. Abbott Laboratories
  • 15.4. Danaher Corporation
  • 15.5. Hologic, Inc.
  • 15.6. BioMerieux SA
  • 15.7. F. Hoffmann-La Roche AG
  • 15.8. Laboratory Corporation of America Holdings
  • 15.9. Allergy Therapeutics plc
  • 15.10. Indoor Biotechnologies, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer